2,887 matches for your search in the start-up spotlight
rss
Founded in Munich in 2017, inveox GmbH develops systems for the digitalization, automation and networking of pathology laboratories. The aim is to increase the safety and reliability of cancer diagnoses, while at the same time boosting the efficiency and profitability of laboratories and ...
HAPILA GmbH is a specialist for sophisticated development services in the pharmaceutical-chemical sector. We offer customers from the pharmaceutical and biotech industries complete solutions for chemical-process engineering problems. In addition to the development of the actual synthesis and ...
Embion is a chemical process technology EPFL spin-off, commercializing a novel catalytic process that allows the use of sustainable resources in the form of 2nd generation lignocellulosic biomass for producing food ingredients, chemicals and fuels. Our process helps reducing the carbon footprint ...
OMEICOS Therapeutics’ is focused on developing therapeutics that can be broadly deployed in inflammatory, cardiovascular, ophthalmology and other disease indications using its proprietary technology and extensive knowledge of omega-3 fatty acid metabolism and biology. Learn more Our pipeline of ...
The successful digitization of products and processes is becoming a decisive factor for corporate success. Unamera is an Internet platform that focuses on the digital transformation of business processes and their integration in a horizontal and vertical direction. The primary goal is to achieve ...
ImevaX, based in Munich, Germany, is a biopharmaceutical company specializing in the development, manufacture and worldwide distribution of Pylori DuoTect®. Pylori DuoTect® is a highly effective and cost-efficient in vitro rapid test for the qualitative determination of specific antibodies ...
Amal Therapeutics SA is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Amal was incorporated on September 3rd 2012 and secured seed funding in February 2014 to establish and validate its technology platform. Boehringer Ingelheim Venture Fund led this ...
